Swiss Pacific Group, Ltd. – Trademark Portfolio

Entity Type: 03

Swiss Pacific Group, Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include SALIVAX and CONTRE VIR. The owner is based in Pleasanton, CA.

c/o ImmunoScience, Inc.

7066-D Commerce Circle

Pleasanton, CA 94588

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Swiss Pacific Group, Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Swiss Pacific Group, Ltd. have?

Swiss Pacific Group, Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 cancelled.

What trademark classes does Swiss Pacific Group, Ltd. file in?

Swiss Pacific Group, Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Swiss Pacific Group, Ltd.'s most well-known trademarks?

Swiss Pacific Group, Ltd.'s registered trademark portfolio includes well-known marks such as SALIVAX and CONTRE VIR. These are among 2 currently registered trademarks in the portfolio.

What is Swiss Pacific Group, Ltd.'s trademark registration success rate?

Swiss Pacific Group, Ltd. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.